Mml Investors Services, LLC Evolus, Inc. Transaction History

Mml Investors Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $21,751 - $38,457	-2,803 Reduced 11.44%	21,689 $175,000
Q2 2022 Aug 12, 2022	SELL	$10.22 - $13.94 $472,593 - $644,613	-46,242 Reduced 65.37%	24,492 $284,000
Q1 2022 May 13, 2022	BUY	$5.22 - $11.78 $205,929 - $464,721	39,450 Added 126.1%	70,734 $794,000
Q4 2021 Feb 14, 2022	BUY	$5.37 - $8.38 $11,319 - $17,665	2,108 Added 7.23%	31,284 $204,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $26,385 - $49,006	3,585 Added 14.01%	29,176 $222,000
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $68,825 - $114,109	8,174 Added 46.93%	25,591 $324,000
Q1 2021 May 14, 2021	BUY	$3.2 - $16.51 $55,734 - $287,554	17,417 New	17,417 $226,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.